Sort
85,873 grants matching “alzheimers”
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias
$4,159,504Anne M Murray · Hennepin Healthcare Research Institute · RF1 · FY2022 · AG
Phenotyping Core
$4,151,830Thomas T Perls · Washington University · U19 · FY2021 · AG
PET Radiopharmaceutical Sciences
$4,151,603Victor W Pike · National Institute Of Mental Health · ZIA · FY2020 · MH
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias
$4,150,513Christopher Mark Norris · University Of Kentucky · P01 · FY2023 · AG
Ambulatory Methods for Measuring Cognitive Change
$4,150,372Martin J. Sliwinski · Pennsylvania State University, The · U2C · FY2022 · AG
Full human gene replacement mouse models of Alzheimer's Disease
$4,147,326Michael D Koob · University Of Minnesota · RF1 · FY2022 · AG
Molecular pathobiology of soluble TREM2 in Alzheimer's disease.
$4,147,115Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute · RF1 · FY2017 · AG
Alzheimer's Disease Genetics Consortium
$4,145,973Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2020 · AG
Glycoproteomics and the Glycosylation Code of the Brain in Asymptomatic and Symptomatic Alzheimerâs Disease
$4,145,414Richard D Cummings · Beth Israel Deaconess Medical Center · RF1 · FY2018 · AG
Functional Networks in Microglia and Astrocytes Regulating Neuropathology of Alzheimer's Disease
$4,144,506Ana Milosevic · Rockefeller University · RF1 · FY2018 · AG
Phenotyping Core
$4,139,779Thomas T Perls · Washington University · U19 · FY2020 · AG
Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study
$4,139,640John Morris · Washington University · P01 · FY2024 · AG
Functional decoding of signaling dynamics in single immune cells
$4,139,523Myong-Hee Sung · National Institute On Aging · ZIA · FY2025 · AG
Stroke Disordered Breathing and its Impact on Cognitive Decline in Aging, Alzheimer's Disease and Cerebral Amyloid Angiopathy
$4,137,716Jun Li · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2020 · AG
Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study
$4,136,684John Morris · Washington University · P01 · FY2023 · AG
API A4 Alzheimer's Prevention Trial
$4,136,602Eric M Reiman · Banner Health · R01 · FY2025 · AG
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias
$4,131,531Christopher Mark Norris · University Of Kentucky · P01 · FY2024 · AG
Cognitive Aging, Brain Morphology, and Arrhythmias in Hispanics/Latinos: Implications for Prevention and Management of Alzheimer's Disease-Related Dementias
$4,131,388Lin Yee Chen · University Of Minnesota · RF1 · FY2022 · NS
A Pilot Synaptic Vesicle Glycoprotein 2A (SV2A) PET Study to Evaluate the Effect of CT1812 Treatment on Synaptic Density in Subjects with Mild to Moderate Alzheimer's Disease
$4,130,741Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2017 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
$4,130,041Emily J Rogalski · Northwestern University At Chicago · U19 · FY2021 · AG
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$4,129,301Frank R Lin · Johns Hopkins University · R01 · FY2018 · AG
Age-Associated Lipidomic Changes in Alzheimer's Disease
$4,126,646Jan Krzysztof Blusztajn · Boston University Medical Campus · RF1 · FY2019 · AG
General Clinical Research Center
$4,124,587A Eugene Washington · University Of California Los Angeles · M01 · FY2010 · RR
General Clinical Research Center
$4,124,587Gerald S Levey · University Of California Los Angeles · M01 · FY2008 · RR
General Clinical Research Center
$4,124,587Gerald S Levey · University Of California Los Angeles · M01 · FY2009 · RR